Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia. (February 2021)

• Record Type: Journal Article
• Authors: Montalban-Bravo, Guillermo; Darbaniyan, Faezeh; Kanagal-Shamanna, Rashmi; Ganan-Gomez, Irene; Class, Caleb A.; Sasaki, Koji; Naqvi, Kiran; Wei, Yue; Yang, Hui; Soltysiak, Kelly A.; Chien, Kelly S.; Bueso-Ramos, Carlos; Do, Kim-Anh; Kantarjian, Hagop; Garcia-Manero, Guillermo
• Is Part Of: Leukemia research. Volume 101(2021)
• Publication Date: 2021-02
• Subjects: Chronic myelomonocytic leukemia -- Interferon -- Transcriptomic -- Outcomes -- RNA -- Monopoiesis; Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2021.106511
• Languages: English
• ISSNs: 0145-2126

Abstract

Highlights: Bone marrow cells from healthy individuals and 19 patients with CMML were compared. Top upregulated genes included IFN alpha and beta signaling. 23 genes involved in regulation of monopoiesis were upregulated in CMML patients. 3 monopoiesis regulation genes differentiated patients into two prognostic subsets. Abstract: Chronic myelomonocytic leukemia (CMML) is characterized by myelomonocytic bias and monocytic proliferation. Whether cell-intrinsic innate immune or inflammatory upregulation mediate disease pathogenesis and phenotype or whether the degree of aberrant monocytic differentiation influences outcomes remains unclear. We compared the transcriptomic features of bone marrow CD34+ cells from 19 patients with CMML and compared to healthy individuals. A total of 1495 genes had significantly differential expression in CMML (q<0.05, fold change>2), including 1271 genes that were significantly upregulated and 224 that were significantly downregulated in CMML. Top upregulated genes were associated with interferon (IFN) alpha and beta signaling, chemokine receptors, IFN gamma, G protein-coupled receptor ligand signaling, and genes involved in immunomodulatory interactions between lymphoid and non-lymphoid cells. Additionally, 6 gene sets were differentially upregulated and 139 were significantly downregulated in patients with myeloproliferative compared to myelodysplastic CMML. A total of 23 genes involved in regulation of monopoiesis were upregulated in CMML compared to healthy controls. We developed a prediction model using Cox regression including 3 of these genes, which differentiated patients into two prognostic subsets with distinct survival outcomes. This data warrants further evaluation of the roles and therapeutic potential of type I IFN signaling and monopoiesis in CMML.